These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32393574)

  • 1. ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy.
    Perez-Gracia JL; Awada A; Calvo E; Amaral T; Arkenau HT; Gruenwald V; Bodoky G; Lolkema MP; Di Nicola M; Penel N; Vera R; Sanmamed MF; Douillard JY
    ESMO Open; 2020 May; 5(3):e000662. PubMed ID: 32393574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials.
    Perez-Gracia JL; Penel N; Calvo E; Awada A; Arkenau HT; Amaral T; Grünwald V; Sanmamed MF; Castelo-Branco L; Bodoky G; Lolkema MP; Di Nicola M; Casali P; Giuliani R; Pentheroudakis G
    Ann Oncol; 2023 Jan; 34(1):70-77. PubMed ID: 36209982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GCP data quality for early clinical development.
    Rock EP; Molloy VJ; Humphrey JS
    Clin Cancer Res; 2010 Mar; 16(6):1756-63. PubMed ID: 20215550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety.
    Blum AB; Shea S; Czeisler CA; Landrigan CP; Leape L
    Nat Sci Sleep; 2011; 3():47-85. PubMed ID: 23616719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.
    Browne LH; Graham PH
    Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the quality conduct and efficiency of clinical trials with training: Recommendations for preparedness and qualification of investigators and delegates.
    Bechtel J; Chuck T; Forrest A; Hildebrand C; Panhuis J; Pattee SR; Comic-Savic S; Swezey T
    Contemp Clin Trials; 2020 Feb; 89():105918. PubMed ID: 31881391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European survey on national training activities in clinical research.
    Magnin A; Iversen VC; Calvo G; Čečetková B; Dale O; Demlova R; Blasko G; Keane F; Kovacs GL; Levy-Marchal C; Monteiro EC; Palmisano L; Pella D; Portolés Pérez A; Rascol O; Schmid C; Tay F; von der Leyen H; Ohmann C
    Trials; 2019 Oct; 20(1):616. PubMed ID: 31665085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-risk trials for children and pregnant women threatened by unnecessary strict regulations. Does the coming EU Clinical Trial Regulation offer a solution?
    Knaapen M; Ploem MC; Kruijt M; Oudijk MA; van der Graaf R; Bet PM; Bakx R; van Heurn LWE; Gorter RR; van der Lee JH
    Eur J Pediatr; 2020 Aug; 179(8):1205-1211. PubMed ID: 32535715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Telecommunications, health and radiology: potential synergies for the new millennium].
    Lagalla R
    Radiol Med; 2001; 102(1-2):14-9. PubMed ID: 11677432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO guidelines for good clinical practice (GCP) for trials on pharmaceutical products: responsibilities of the investigator.
    Idänpään-Heikkilä JE
    Ann Med; 1994 Apr; 26(2):89-94. PubMed ID: 8024733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigator barriers and preferences to conduct clinical drug trials in Finland: a qualitative study.
    Keinonen T; Keränen T; Klaukka T; Saano V; Ylitalo P; Enlund H
    Pharm World Sci; 2003 Dec; 25(6):251-9. PubMed ID: 14689812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Care Research Team Assessment (PCRTA): development and evaluation.
    Carter YH; Shaw S; Macfarlane F
    Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences with GCP in the pharmaceutical industry [corrected].
    Rämsch KD
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):237-40. PubMed ID: 8240533
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.